Raffaella Mormile
doi : 10.1080/17512433.2023.2154650
Expert Review of Clinical Pharmacology, Volume 16, Issue 1 (2023)
Gianluca Bossù, Giovanni Autore, Luca Bernardi, Danilo Buonsenso, Giovanni Battista Migliori & Susanna Esposito
doi : 10.1080/17512433.2023.2148653
According to the latest report from the World Health Organization (WHO), approximately 10.0 million people fell ill with tuberculosis (TB) in 2020, 12% of which were children aged under 15 years. There is very few experience on treatment of multi-drug resistant (MDR)-TB in pediatrics.
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini & Alba Ariela Brandes
doi : 10.1080/17512433.2023.2163385
Diffuse midline gliomas (DMG) and diffuse hemispheric glioma (DHG) are both rare tumors characterized and recognized for specific alterations of histone 3 including H3K27 (DMG) and H3G34 (DHG). Despite these tumors arising from alterations of the same gene their clinical, radiological, and molecular behaviors strongly diverge, requiring a personalized therapeutic approach.
Mattia Galli, Francesco Franchi, Fabiana Rollini, Luis Ortega-Paz, Domenico D’Amario, Raffaele De Caterina, Roxana Mehran, C Michael Gibson & Dominick J. Angiolillo
doi : 10.1080/17512433.2023.2154651
The persistence of elevated rates of ischemic recurrences despite the use of antiplatelet therapy among patients with atherosclerotic disease together with the understanding of the pivotal role of coagulation in the thrombo-inflammatory processes involved in the pathogenesis of atherosclerosis and its complications has fostered the development of treatments targeting both platelets and coagulation, a strategy known as dual-pathway inhibition (DPI).
doi : 10.1080/17512433.2023.2161045
Recent evidence has linked long-term use of angiotensin converting enzyme (ACE) inhibitors with the risk of developing lung cancer by increasing levels of substance P (SP) and bradykinin in lung tissue. DPP-4 inhibitors, by virtue of their mechanism of action, may increase the level of SP and pose a similar risk of incident lung cancer. Concomitant use of DPP-4 inhibitors and ACE inhibitors may further exaggerate this plausible risk.
Harmanjit Singh, Jasbir Singh, Ravneet Kaur Bhangu, Mandeep Singla, Jagjit Singh & Farideh Javid
doi : 10.1080/17512433.2023.2163386
Based on pharmacological properties and results from clinical studies, teneligliptin has a great potential to be used as an alternate-day therapy and also the daily dose can be reduced to 10 mg. Clinical data also suggest its excellent efficacy and safety among older subjects.
Sagar Dholariya, Deepak Parchwani, Siddhartha Dutta & Ragini Singh
doi : 10.1080/17512433.2023.2138343
This study was carried out to analyze the clinical safety and efficacy of dasiglucagon for the treatment of severe hypoglycemia in patients with type 1 diabetes mellitus (T1DM).
Parisa Rahmani, Ebru Melekoglu, Sogand Tavakoli, Nasser Malekpour Alamdari, Pejman Rohani & Mohammad Hassan Sohouli
doi : 10.1080/17512433.2023.2138342
Dyslipidemia/hyperlipidemia are among the risk factors for chronic diseases, especially cardiovascular diseases. Red Yeast Rice (RYR) herbal supplement may be helpful in improving serum fat levels due to some mechanisms. Therefore, the aim of this study was to evaluate the effects of RYR consumption on total serum cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels in adults.
Lin Song, Chen-Rong Huang, Shi-Zheng Pan, Jian-Guo Zhu, Zong-Qi Cheng, Xun Yu, Ling Xue, Fan Xia, Jin-Yuan Zhang, De-Pei Wu & Li-Yan Miao
doi : 10.1080/17512433.2023.2142561
Cyclosporin A is a calcineurin inhibitor which has a narrow therapeutic window and high interindividual variability. Various population pharmacokinetic models have been reported; however, professional software and technical personnel were needed and the variables of the models were limited. Therefore, the aim of this study was to establish a model based on machine learning to predict CsA trough concentrations in Chinese allo-HSCT patients.
Do you want to add Medilib to your home screen?